These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38284386)

  • 1. Dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer.
    El-Tanani M; Nsairat H; Aljabali AA; Matalka II; Alkilany AM; Tambuwala MM
    Expert Opin Drug Deliv; 2024 Feb; 21(2):309-324. PubMed ID: 38284386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells.
    Haggag Y; Abu Ras B; El-Tanani Y; Tambuwala MM; McCarron P; Isreb M; El-Tanani M
    Expert Opin Drug Deliv; 2020 Nov; 17(11):1655-1669. PubMed ID: 32841584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
    Sen K; Banerjee S; Mandal M
    Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted multidrug delivery system to overcome chemoresistance in breast cancer.
    Tang Y; Soroush F; Tong Z; Kiani MF; Wang B
    Int J Nanomedicine; 2017; 12():671-681. PubMed ID: 28176940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancer.
    Bai F; Yin Y; Chen T; Chen J; Ge M; Lu Y; Xie F; Zhang J; Wu K; Liu Y
    Int J Nanomedicine; 2018; 13():1327-1339. PubMed ID: 29563790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC.
    Pal K; Madamsetty VS; Dutta SK; Mukhopadhyay D
    Int J Nanomedicine; 2019; 14():5109-5123. PubMed ID: 31371950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
    Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y
    Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temperature-sensitive liposomes for co-delivery of tamoxifen and imatinib for synergistic breast cancer treatment.
    Jose A; Ninave KM; Karnam S; Venuganti VVK
    J Liposome Res; 2019 Jun; 29(2):153-162. PubMed ID: 30022700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updates on the use of liposomes for active tumor targeting in cancer therapy.
    Yan W; Leung SS; To KK
    Nanomedicine (Lond); 2020 Feb; 15(3):303-318. PubMed ID: 31802702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoresistance mechanisms of breast cancer and their countermeasures.
    Ji X; Lu Y; Tian H; Meng X; Wei M; Cho WC
    Biomed Pharmacother; 2019 Jun; 114():108800. PubMed ID: 30921705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The benefits and challenges associated with the use of drug delivery systems in cancer therapy.
    Cukierman E; Khan DR
    Biochem Pharmacol; 2010 Sep; 80(5):762-70. PubMed ID: 20417189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft model.
    Cordeiro Pedrosa LR; van Tellingen O; Soullié T; Seynhaeve AL; Eggermont AM; Ten Hagen TL; Verheij M; Koning GA
    Eur J Pharm Biopharm; 2015 Aug; 94():207-19. PubMed ID: 25982691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano-Based Drug Delivery of Anticancer Chemotherapeutic Drugs Targeting Breast Cancer.
    Behl A; Chhillar AK
    Recent Pat Anticancer Drug Discov; 2023; 18(3):325-342. PubMed ID: 35702804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.
    Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A
    Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinational drug delivery using nanocarriers for breast cancer treatments: A review.
    Olov N; Bagheri-Khoulenjani S; Mirzadeh H
    J Biomed Mater Res A; 2018 Aug; 106(8):2272-2283. PubMed ID: 29577607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells.
    Li N; Fu T; Fei W; Han T; Gu X; Hou Y; Liu Y; Yang J
    J Pharm Pharmacol; 2019 Aug; 71(8):1243-1254. PubMed ID: 31215039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-Functional Liposomes with Carbonic Anhydrase IX Antibody and BR2 Peptide Modification Effectively Improve Intracellular Delivery of Cantharidin to Treat Orthotopic Hepatocellular Carcinoma Mice.
    Zhang X; Lin C; Chan W; Liu K; Lu A; Lin G; Hu R; Shi H; Zhang H; Yang Z
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31547459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From conventional to stealth liposomes: a new Frontier in cancer chemotherapy.
    Cattel L; Ceruti M; Dosio F
    J Chemother; 2004 Nov; 16 Suppl 4():94-7. PubMed ID: 15688621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.
    Shahin M; Soudy R; El-Sikhry H; Seubert JM; Kaur K; Lavasanifar A
    Cancer Lett; 2013 Jul; 334(2):284-92. PubMed ID: 23073474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.